Jing-Ping Liou

2025

Advancing glioblastoma therapy: Learning from the past and innovations for the future

Rana, M., Liou, K. C., Thakur, A., Nepali, K. & Liou, J. P., 5月 1 2025, 於: Cancer Letters. 617, 217601.

研究成果: 雜誌貢獻 › 文章 › 同行評審

Design, preparation, and characterization of injectable thermosensitive polymer-based hydrogels with enhanced mechanical properties for sustained liraglutide release

Cheng, W. J., Yeh, T. Y., Hsieh, C. Y., Chuang, H. Y., Chao, F. C., Liou, J. P. & Hsieh, C. M., 6月 2025, 於: Journal of Drug Delivery Science and Technology. 108, 106909.

研究成果: 雜誌貢獻 › 文章 › 同行評審

Development of BACE2-IN-1/tranylcypromine-based compounds to induce steroidogenesis-dependent neuroprotection

Banerjee, S., Hsu, Y. T., Nguyen, D. H., Yeh, S. H., Liou, K. C., Liu, J. J., Liou, J. P. & Chuang, J. Y., 2月 2025, 於: Biomedicine and Pharmacotherapy. 183, 117851.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Repurposing Linezolid in Conjunction with Histone Deacetylase Inhibitor Access in the Realm of Glioblastoma Therapies

Chen, I. C., Lin, H. Y., Liu, Z. Y., Cheng, W. J., Yeh, T. Y., Yang, W. B., Tran, H. Y., Lai, M. J., Wang, C. H., Kao, T. Y., Hung, C. Y., Huang, Y. L., Liou, K. C., Hsieh, C. M., Hsu, T. I. & Liou, J. P., 2025, 於: Journal of Medicinal Chemistry. 68, 3, p. 2779-2803 25 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

2024

Design, synthesis, and biological evaluation of adenosine derivatives targeting DOT1L and HAT as anti-leukemia agents

Sethy, B., Yu, Z. Y., Narwanti, I., Upadhyay, R., Lai, M. J., Lee, S. B. & Liou, J. P., 12月 2024, 於: Bioorganic Chemistry. 153, 107771.

研究成果: 雜誌貢獻 › 文章 › 同行評審

Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress

Sharma, R., Chiang, Y. H., Chen, H. C., Lin, H. Y., Yang, W. B., Nepali, K., Lai, M. J., Chen, K. Y., Liou, J. P. & Hsu, T. I., 4月 1 2024, 於: Cancer Letters. 586, 216666.

研究成果: 雜誌貢獻 › 文章 › 同行評審

5 引文斯高帕斯（Scopus）

Effect of Sulfotyrosine and Negatively Charged Amino Acid of Leech-Derived Peptides on Binding and Inhibitory Activity Against Thrombin

Chen, T.-Y., Shyur, E., Ma, T.-H., Wijeyewickrema, L., Lin, S.-W., Kao, M.-R., Liang, P.-H., Shie, J.-J., Chuang, E.-Y., Liou, J.-P. & Hsieh, Y. S., 2月 1 2024, 於: ChemBioChem. 25, 3, p. e202300744 e202300744.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo

Sharma, S., Wang, S. A., Yang, W. B., Lin, H. Y., Lai, M. J., Chen, H. C., Kao, T. Y., Hsu, F. L., Nepali, K., Hsu, T. I. & Liou, J. P., 2月 22 2024, 於: Journal of Medicinal Chemistry. 67, 4, p. 2963-2985 23 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

4 引文斯高帕斯（Scopus）

HSP90/LSD1 dual inhibitors against prostate cancer as well as patient-derived colorectal organoids

Tang, D. W., Chen, I. C., Chou, P. Y., Lai, M. J., Liu, Z. Y., Tsai, K. K., Cheng, L. H., Zhao, J. X., Cho, E. C., Chang, H. H., Lin, T. E., Hsu, K. C., Chen, M. C. & Liou, J. P., 11月 15 2024, 於: European Journal of Medicinal Chemistry. 278, 116801.

研究成果: 雜誌貢獻 › 文章 › 同行評審

1 引文斯高帕斯（Scopus）

Leveraging a rationally designed veliparib-based anilide eliciting anti-leukemic effects for the design of pH-responsive polymer nanoformulation

Thakur, A., Chu, Y. H., Rao, N. V., Mathew, J., Grewal, A. S., Prabakaran, P., Guru, S., Liou, J. P., Pan, C. H. & Nepali, K., 7月 5 2024, 於: European Journal of Medicinal Chemistry. 273, 116507.

研究成果: 雜誌貢獻 › 文章 › 同行評審

1 引文斯高帕斯（Scopus）

MPT0E028, a novel pan-HDAC inhibitor, prevents pulmonary fibrosis through inhibition of TGF-β-induced CTGF expression in human lung fibroblasts: Involvement of MKP-1 activation

Liu, C. H., Lee, H. S., Liou, J. P., Hua, H. S., Cheng, W. H., Yuliani, F. S., Chen, B. C. & Lin, C. H., 8月 15 2024, 於: European Journal of Pharmacology. 977, 176711.

研究成果: 雜誌貢獻 › 文章 › 同行評審

1 引文斯高帕斯（Scopus）

Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer

Sethy, B., Upadhyay, R., Narwanti, I., Yu, Z. Y., Lee, S. B. & Liou, J. P., 2024, (接受/付印) 於: Apoptosis. 29, 11-12, p. 2047-2073 27 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

Rationally designed febuxostat-based hydroxamic acid and its pH-Responsive nanoformulation elicits anti-tumor activity

Ritika, Liao, Z. Y., Chen, P. Y., Rao, N. V., Mathew, J., Sharma, R., Grewal, A. S., Singh, G., Mehan, S., Liou, J. P., Pan, C. H. & Nepali, K., 2024, 於: European Journal of Medicinal Chemistry. 279, 116866.

研究成果: 雜誌貢獻 › 文章 › 同行評審

Syntheses of LSD1/HDAC Inhibitors with Demonstrated Efficacy against Colorectal Cancer: In Vitro and In Vivo Studies Including Patient-Derived Organoids

Chou, P. Y., Lai, M. J., Tsai, K. K., Cheng, L. H., Wu, Y. W., Chen, M. C., Pan, S. L., Ho, H. O., Nepali, K. & Liou, J. P., 2024, (接受/付印) 於: Journal of Medicinal Chemistry. 67, 19, p. 17207-17225 19 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

2023

6-Regioisomeric 5,8-quinolinediones as potent CDC25 inhibitors against colorectal cancers

Narwanti, I., Yu, Z. Y., Sethy, B., Lai, M. J., Lee, H. Y., Olena, P., Lee, S. B. & Liou, J. P., 10月 2023, 於: European Journal of Medicinal Chemistry. 258, 115505.

研究成果: 雜誌貢獻 › 文章 › 同行評審

7 引文斯高帕斯（Scopus）

Anticancer Study of a Novel Pan-HDAC Inhibitor MPT0G236 in Colorectal Cancer Cells

Tsai, F. L., Huang, H. L., Lai, M. J., Liou, J. P., Pan, S. L. & Yang, C. R., 8月 2023, 於: International journal of molecular sciences. 24, 16, 12588.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma

Tseng, H. J., Banerjee, S., Qian, B., Lai, M. J., Wu, T. Y., Hsu, T. I., Lin, T. E., Hsu, K. C., Chuang, K. H., Liou, J. P. & Shih, J. C., 8月 2023, 於: European Journal of Medicinal Chemistry. 256, 115459.

研究成果: 雜誌貢獻 › 文章 › 同行評審

10 引文斯高帕斯（Scopus）

Flavone-based dual PARP-Tubulin inhibitor manifesting efficacy against endometrial cancer

Sharma, S., Chandra, K., Naik, A., Sharma, A., Sharma, R., Thakur, A., Grewal, A. S., Dhingra, A. K., Banerjee, A., Liou, J. P., Guru, S. K. & Nepali, K., 2023, 於: Journal of Enzyme Inhibition and Medicinal Chemistry. 38, 1, 2276665.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

4 引文斯高帕斯（Scopus）

Rational design of synthetically tractable HDAC6/HSP90 dual inhibitors to destroy immune-suppressive tumor microenvironment

Wu, T. Y., Chen, M., Chen, I. C., Chen, Y. J., Chen, C. Y., Wang, C. H., Cheng, J. J., Nepali, K., Chuang, K. H. & Liou, J. P., 4月 2023, 於: Journal of Advanced Research. 46, p. 159-171 13 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

16 引文斯高帕斯（Scopus）

Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effects

Nepali, K., Wu, A. C., Lo, W. L., Chopra, B., Lai, M. J., Chuang, J. Y. & Liou, J. P., 2月 2023, 於: European Journal of Medicinal Chemistry. 248, 115054.

研究成果: 雜誌貢獻 › 文章 › 同行評審

10 引文斯高帕斯（Scopus）

2022

2,6-Difluorobenzamide derivatives as store-operated calcium channel (SOC) inhibitors

Wang, Y. S., Yeh, T. K., Chang, W. C., Liou, J. P., Liu, Y. M. & Huang, W. C., 12月 5 2022, 於: European Journal of Medicinal Chemistry. 243, 114773.

研究成果: 雜誌貢獻 › 文章 › 同行評審

3 引文斯高帕斯（Scopus）

Accommodation of ring C expanded deoxyvasicinone in the HDAC inhibitory pharmacophore culminates into a tractable anti-lung cancer agent and pH-responsive nanocarrier

Sharma, R., Chatterjee, E., Mathew, J., Sharma, S., Rao, N. V., Pan, C. H., Lee, S. B., Dhingra, A., Grewal, A. S., Liou, J. P., Guru, S. K. & Nepali, K., 10月 5 2022, 於: European Journal of Medicinal Chemistry. 240, 114602.

研究成果: 雜誌貢獻 › 文章 › 同行評審

8 引文斯高帕斯（Scopus）

A Potent Histone Deacetylase Inhibitor MPT0E028 Mitigates Emphysema Severity via Components of the Hippo Signaling Pathway in an Emphysematous Mouse Model

Yeh, L.-Y., Fang, Y.-T., Lee, H.-S., Liu, C.-H., Chen, Y.-Y., Lo, Y.-C., Laiman, V., Liou, J.-P., Chung, K. F., Chuang, H.-C. & Lin, C.-H., 5月 2022, 於: Frontiers in Medicine. 9, 794025.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells

Wu, A. C., Yang, W. B., Chang, K. Y., Lee, J. S., Liou, J. P., Su, R. Y., Cheng, S. M., Hwang, D. Y., Kikkawa, U., Hsu, T. I., Wang, C. Y., Chang, W. C., Chen, P. Y. & Chuang, J. Y., 12月 2022, 於: Journal of Experimental and Clinical Cancer Research. 41, 1, 47.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

18 引文斯高帕斯（Scopus）

N-Methylpropargylamine-Conjugated Hydroxamic Acids as Dual Inhibitors of Monoamine Oxidase A and Histone Deacetylase for Glioma Treatment

Mehndiratta, S., Qian, B., Chuang, J. Y., Liou, J. P. & Shih, J. C., 2月 2022, 於: Journal of Medicinal Chemistry. 65, 3, p. 2208-2224 17 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

16 引文斯高帕斯（Scopus）

Structural compositions and biological activities of cell wall polysaccharides in the rhizome, stem, and leaf of Polygonatum odoratum (Mill.) Druce

Li, J., Hsiung, S. Y., Kao, M. R., Xing, X., Chang, S. C., Wang, D., Hsieh, P. Y., Liang, P. H., Zhu, Z., Cheng, T. J. R., Shie, J. J., Liou, J. P., Abbott, D. W., Kwon, S. W. & Hsieh, Y. S. Y., 11月 2022, 於: Carbohydrate Research. 521, 108662.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

12 引文斯高帕斯（Scopus）

2021

A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo

Wu, Y. W., Chao, M. W., Tu, H. J., Chen, L. C., Hsu, K. C., Liou, J. P., Yang, C. R., Yen, S. C., HuangFu, W. C. & Pan, S. L., 5月 2021, 於: Oncogenesis. 10, 5, 39.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

20 引文斯高帕斯（Scopus）

A novel histone deacetylase inhibitor MPT0L184 dysregulates cell-cycle checkpoints and initiates unscheduled mitotic signaling

Chang, T. Y., Nepali, K., Chen, Y. Y., Yang, Y. C. S. H., Hsu, K. C., Yen, Y., Pan, S. L., Liou, J. P. & Lee, S. B., 6月 2021, 於: Biomedicine and Pharmacotherapy. 138, 111485.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

6 引文斯高帕斯（Scopus）

CAP rigidification of MS-275 and chidamide leads to enhanced antiproliferative effects mediated through HDAC1, 2 and tubulin polymerization inhibition

Singh, A., Chang, T. Y., Kaur, N., Hsu, K. C., Yen, Y., Lin, T. E., Lai, M. J., Lee, S. B. & Liou, J. P., 4月 5 2021, 於: European Journal of Medicinal Chemistry. 215, 113169.

研究成果: 雜誌貢獻 › 文章 › 同行評審

29 引文斯高帕斯（Scopus）

Combining an autophagy inhibitor, mpt0l145, with abemaciclib is a new therapeutic strategy in gbm treatment

Hsieh, T. H., Liang, M. L., Zheng, J. H., Lin, Y. C., Yang, Y. C. S. H., Vo, T. H., Liou, J. P., Yen, Y. & Chen, C. H., 12月 1 2021, 於: Cancers. 13, 23, 6117.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

5 引文斯高帕斯（Scopus）

Effect of 3-subsitution of quinolinehydroxamic acids on selectivity of histone deacetylase isoforms

Mehndiratta, S., Chen, M. C., Chao, Y. H., Lee, C. H., Liou, J. P., Lai, M. J. & Lee, H. Y., 1月 1 2021, 於: Journal of Enzyme Inhibition and Medicinal Chemistry. 36, 1, p. 74-84 11 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

8 引文斯高帕斯（Scopus）

Erratum: TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis: Erratum

Huang, H. L., Liu, Y. M., Sung, T. Y., Huang, T. C., Cheng, Y. W., Liou, J. P. & Pan, S. L., 1月 1 2021, 於: Theranostics. 11, 5, p. 2079 1 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells

Yang, W. B., Wu, A. C., Hsu, T. I., Liou, J. P., Lo, W. L., Chang, K. Y., Chen, P. Y., Kikkawa, U., Yang, S. T., Kao, T. J., Chen, R. M., Chang, W. C., Ko, C. Y. & Chuang, J. Y., 10月 2021, 於: Cell Death and Disease. 12, 10, 884.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

19 引文斯高帕斯（Scopus）

Installation of Pargyline, a LSD1 Inhibitor, in the HDAC Inhibitory Template Culminated in the Identification of a Tractable Antiprostate Cancer Agent

Ojha, R., Chen, I. C., Hsieh, C. M., Nepali, K., Lai, R. W., Hsu, K. C., Lin, T. E., Pan, S. L., Chen, M. C. & Liou, J. P., 2021, (接受/付印) 於: Journal of Medicinal Chemistry. 64, 24, p. 17824-17845 22 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

25 引文斯高帕斯（Scopus）

Optimization and development of selective histone deacetylase inhibitor (Mpt0b291)-loaded albumin nanoparticles for anticancer therapy

Putri, A. D., Chen, P. S., Su, Y. L., Lin, J. P., Liou, J. P. & Hsieh, C. M., 10月 2021, 於: Pharmaceutics. 13, 10, 1728.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

11 引文斯高帕斯（Scopus）

Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: A preliminary attempt to unravel the enigma of glioblastoma

Nepali, K., Hsu, T. I., Hsieh, C. M., Lo, W. L., Lai, M. J., Hsu, K. C., Lin, T. E., Chuang, J. Y. & Liou, J. P., 5月 5 2021, 於: European Journal of Medicinal Chemistry. 217, 113338.

研究成果: 雜誌貢獻 › 文章 › 同行評審

17 引文斯高帕斯（Scopus）

Ring-opening of five-membered heterocycles conjugated 4-isopropylresorcinol scaffold-based benzamides as HSP90 inhibitors suppressing tumor growth in vitro and in vivo

Liu, Y. M., Tu, H. J., Wu, C. H., Lai, M. J., Yu, S. C., Chao, M. W., Wu, Y. W., Teng, C. M., Pan, S. L. & Liou, J. P., 7月 5 2021, 於: European Journal of Medicinal Chemistry. 219, 113428.

研究成果: 雜誌貢獻 › 文章 › 同行評審

12 引文斯高帕斯（Scopus）

Suppression of extracellular vesicle VEGF-C-mediated lymphangiogenesis and pancreatic cancer early dissemination by a selective HDAC1/2 inhibitor

Wang, C. A., Li, C. F., Huang, R. C., Li, Y. H., Liou, J. P. & Tsai, S. J., 9月 2021, 於: Molecular Cancer Therapeutics. 20, 9, p. 1550-1560 11 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

11 引文斯高帕斯（Scopus）

2020

CK1δ as a potential therapeutic target to treat bladder cancer

Lin, Y. C., Chen, M. C., Hsieh, T. H., Liou, J. P. & Chen, C. H., 4月 15 2020, 於: Aging. 12, 7, p. 5764-5780 17 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

10 引文斯高帕斯（Scopus）

Design, synthesis, and evaluation of N-phenyl-4-(2-phenylsulfonamido)-benzamides as microtubule-targeting agents in drug-resistant cancer cells, displaying HDAC inhibitory response

Wu, W. C., Liu, Y. M., Lin, M. H., Liao, Y. H., Lai, M. J., Chuang, H. Y., Hung, T. Y., Chen, C. H. & Liou, J. P., 4月 15 2020, 於: European Journal of Medicinal Chemistry. 192, p. 112158 112158.

研究成果: 雜誌貢獻 › 文章 › 同行評審

14 引文斯高帕斯（Scopus）

Fluoropyrimidin-2,4-dihydroxy-5-isopropylbenzamides as antitumor agents against CRC and NSCLC cancer cells

Wu, W. C., Liu, Y. M., Liao, Y. H., Hsu, K. C., Lien, S. T., Chen, I. C., Lai, M. J., Li, Y. H., Pan, S. L., Chen, M. C. & Liou, J. P., 10月 1 2020, 於: European Journal of Medicinal Chemistry. 203, 112540.

研究成果: 雜誌貢獻 › 文章 › 同行評審

9 引文斯高帕斯（Scopus）

HDAC inhibitor protects chronic cerebral hypoperfusion and oxygen-glucose deprivation injuries via H3K14 and H4K5 acetylation-mediated BDNF expression

Fang, Y.-C., Chan, L., Liou, J.-P., Tu, Y.-K., Lai, M.-J., Chen, C.-I., Vidyanti, A. N., Lee, H.-Y. & Hu, C.-J., 6月 1 2020, 於: Journal of Cellular and Molecular Medicine. 24, 12, p. 6966-6977 12 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

14 引文斯高帕斯（Scopus）

Histone deacetylase inhibitor MPT0B291 suppresses glioma growth in vitro and in vivo partially through acetylation of p53

Buyandelger, B., Bar, E. E., Hung, K. S., Chen, R. M., Chiang, Y. H., Liou, J. P., Huang, H. M. & Wang, J. Y., 2020, 於: International Journal of Biological Sciences. 16, 16, p. 3184-3199 16 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

22 引文斯高帕斯（Scopus）

Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma

Yang, W.-B., Hsu, C.-C., Hsu, T.-I., Liou, J.-P., Chang, K.-Y., Chen, P.-Y., Liu, J.-J., Yang, S.-T., Wang, J.-Y., Yeh, S.-H., Chen, R.-M., Chang, W.-C. & Chuang, J.-Y., 10月 1 2020, 於: Neuro-Oncology. 22, 10, p. 1439-1451 13 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

86 引文斯高帕斯（Scopus）

Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo

Ojha, R., Nepali, K., Chen, C. H., Chuang, K. H., Wu, T. Y., Lin, T. E., Hsu, K. C., Chao, M. W., Lai, M. J., Lin, M. H., Huang, H. L., Chang, C. D., Pan, S. L., Chen, M. C. & Liou, J. P., 3月 15 2020, 於: European Journal of Medicinal Chemistry. 190, 112086.

研究成果: 雜誌貢獻 › 文章 › 同行評審

33 引文斯高帕斯（Scopus）

N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression

Mehndiratta, S., Lin, M. H., Wu, Y. W., Chen, C. H., Wu, T. Y., Chuang, K. H., Chao, M. W., Chen, Y. Y., Pan, S. L., Chen, M. C. & Liou, J. P., 1月 1 2020, 於: European Journal of Medicinal Chemistry. 185, p. 111725 111725.

研究成果: 雜誌貢獻 › 文章 › 同行評審

48 引文斯高帕斯（Scopus）

Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment

Kaur, N., Fang, Y. C., Lee, H. Y., Singh, A., Nepali, K., Lin, M. H., Yeh, T. K., Lai, M. J., Chan, L., Tu, Y. K., Banerjee, S., Hu, C. J. & Liou, J. P., 2月 1 2020, 於: European Journal of Medicinal Chemistry. 187, 111915.

研究成果: 雜誌貢獻 › 文章 › 同行評審

15 引文斯高帕斯（Scopus）

Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitors

Nepali, K., Chang, T. Y., Lai, M. J., Hsu, K. C., Yen, Y., Lin, T. E., Lee, S. B. & Liou, J. P., 6月 15 2020, 於: European Journal of Medicinal Chemistry. 196, 112291.

研究成果: 雜誌貢獻 › 文章 › 同行評審

39 引文斯高帕斯（Scopus）

Synthesis and biological evaluation of 2-quinolineacrylamides

Wang, S. W., Lin, M. H., Hsu, F. C., Chen, M. C., Liou, J. P., Liu, Y. T., Chen, S. S. & Lee, H. Y., 2月 1 2020, 於: Bioorganic and Medicinal Chemistry. 28, 3, p. 115250 115250.

研究成果: 雜誌貢獻 › 文章 › 同行評審

5 引文斯高帕斯（Scopus）

2019

1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase

Lai, M. J., Ojha, R., Lin, M. H., Liu, Y. M., Lee, H. Y., Lin, T. E., Hsu, K. C., Chang, C. Y., Chen, M. C., Nepali, K., Chang, J. Y. & Liou, J. P., 1月 15 2019, 於: European Journal of Medicinal Chemistry. 162, p. 612-630 19 p.

研究成果: 雜誌貢獻 › 文章 › 同行評審

41 引文斯高帕斯（Scopus）

劉 景平

研究成果

搜尋結果

劉景平